Properties of BPC-157 Molecular Formula: CHNO Synonyms: BPC157, BPC 157, Bepecin, 8ED8NXK95P, Bpc 15, PLD-116, PL-14736, pl-10, Body protection compound 15 IUPAC Name: (4S)-4-[(2-aminoacetyl)amino]-5-[(2S)-2-[(2S)-2-[(2S)-2-[[2-[[(2S)-6-amino-1-[(2S)-2-[[(2S)-1-[[2-[[(2S)-1-[[(1S)-1-carboxy-2-methylpropyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxohexan-2-yl]amino]-2-oxoethyl]carbamoyl]pyrrolidine-1-carbonyl]pyrrolidine-1-carbonyl]pyrrolidin-1-yl]-5-oxopentanoic acid Molecular weight: 1419.5 g/mol CAS Number: 137525-51-0 PubChem CID: 155977614 Research Findings on BPC-157 A study has focused on the role of BPC-157 in angiogenesis and tissue repair mechanisms
Contact us at [email protected] 0 Sign in Customer Login If you are already registered, please log in
While the tightening of regulations might raise concerns, the primary goal is to enhance patient safety
Treatment-Resistant Tendinopathy Patients: Individuals whose chronic tendinopathy has not responded to 6 or more months of physical therapy, corticosteroid injections, and NSAIDs are likely to explore unproven adjunct options (BPC-157)
